Sara Rezzola
Overview
Explore the profile of Sara Rezzola including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
620
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mazzoldi E, Benini G, Ferraro R, Micheletti M, Martellosio G, Balduchelli V, et al.
Hum Cell
. 2025 Feb;
38(2):52.
PMID: 39937308
Hyalocytes are macrophage-like cells residing in the eye vitreous cortex. Even though hyalocytes have been firstly described in the mid-Nineteenth century, they have been poorly explored. Recent researches highlighted hyalocyte...
2.
Schiavon E, Rezzola S, Filippi E, Turati M, Parrasia S, Bernardotto S, et al.
Nanomedicine
. 2024 Sep;
62:102784.
PMID: 39236938
In targeted cancer therapy, antibody-drug-conjugates using mertansine (DM1)-based cytotoxic compounds rely on covalent bonds for drug conjugation. Consequently, the cytotoxic DM1 derivative released upon their proteolytic digestion is up to...
3.
Loda A, Semeraro F, Parolini S, Ronca R, Rezzola S
Biochim Biophys Acta Rev Cancer
. 2024 May;
1879(3):189104.
PMID: 38701937
Uveal melanoma (UM) is the most common primary ocular tumor in the adult population. Even though these primary tumors are successfully treated in 90% of cases, almost 50% of patients...
4.
Giacomini A, Turati M, Grillo E, Rezzola S, Ghedini G, Schuind A, et al.
Exp Hematol Oncol
. 2023 Sep;
12(1):82.
PMID: 37749607
Background: The pattern recognition receptor long pentraxin-3 (PTX3) plays conflicting roles in cancer by acting as an oncosuppressor or as a pro-tumor mediator depending on tumor context. Triple negative breast...
5.
Loda A, Calza S, Giacomini A, Ravelli C, Krishna Chandran A, Tobia C, et al.
Cancer Cell Int
. 2023 May;
23(1):89.
PMID: 37165394
Background: Cancer stem-like cells (CSCs) are a subpopulation of tumor cells responsible for tumor initiation, metastasis, chemoresistance, and relapse. Recently, CSCs have been identified in Uveal Melanoma (UM), which represents...
6.
Baronio M, Gazzurelli L, Rezzola S, Rossi S, Tessarin G, Marinoni M, et al.
Immunobiology
. 2023 Apr;
228(3):152381.
PMID: 37086690
Dominant negative mutations in CARD11 have been reported in patients with immune dysregulation, severe atopic features, and variable T cell alterations. Data on Natural killer (NK) cells from affected patients...
7.
Ferrara M, Loda A, Coco G, Grassi P, Cestaro S, Rezzola S, et al.
J Clin Med
. 2023 Feb;
12(3).
PMID: 36769560
Diabetic retinopathy (DR), the most common microvascular complication of diabetes mellitus, represents the leading cause of acquired blindness in the working-age population. Due to the potential absence of symptoms in...
8.
Mahmoud A, Kostrzewa M, Marolda V, Cerasuolo M, Maccarinelli F, Coltrini D, et al.
Pharmacol Res
. 2023 Feb;
189:106683.
PMID: 36736415
In spite of the huge advancements in both diagnosis and interventions, hormone refractory prostate cancer (HRPC) remains a major hurdle in prostate cancer (PCa). Metabolic reprogramming plays a key role...
9.
Turati M, Giacomini A, Rezzola S, Maccarinelli F, Gazzaroli G, Valentino S, et al.
Exp Hematol Oncol
. 2022 Nov;
11(1):84.
PMID: 36320051
The lymphatic vascular system represents a major route for dissemination of several solid tumors, including melanoma. Even though the members of the Vascular Endothelial Growth Factor family VEGF-C and VEGF-A...
10.
Codenotti S, Zizioli D, Mignani L, Rezzola S, Tabellini G, Parolini S, et al.
Cells
. 2022 Sep;
11(18).
PMID: 36139434
In pediatric rhabdomyosarcoma (RMS), elevated Akt signaling is associated with increased malignancy. Here, we report that expression of a constitutively active, myristoylated form of Akt1 (myrAkt1) in human RMS RD...